Wednesday, August 8, 2018

Investor Ideas #Potcasts #Cannabis News and #Stocks on the Move: TSX: $APH.TO, TSX: $ACB.TO, TSX: $CLIQ.TO, TSX: $WEED.TO, TSX: $TRST.TO, CSE: $MTEC.C, CSE: $MYM.C


Investor Ideas #Potcasts #Cannabis News and #Stocks on the Move: TSX: $APH.TO, TSX: $ACB.TO, TSX: $CLIQ.TO, TSX: $WEED.TO, TSX: $TRST.TO, CSE: $MTEC.C, CSE: $MYM.C



Delta, Kelowna, BC – August 8, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca  release today’s edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.


Listen to the podcast:



Today’s podcast overview/transcript:

Good morning and welcome to another Investorideas.com potcast – looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today we will be looking at announcements from Aphria Inc. trading on the TSX as APH and US OTC as APHQF, Aurora Cannabis Inc. trading on the TSX as ACB and the OTCQB as ACBFF, Alcanna Inc. trading on the TSX as CLIQ, Canopy Growth Corporation trading on the TSX as WEED and the NYSE as CGC, CannTrust Holdings Inc. trading on the TSX as TRST,
Cannvas MedTech Inc. trading on the CSE as MTEC and MYM Nutraceuticals Inc., trading on the CSE as MYM and the OTC as MYMMF.

Aphria Inc. today announced that it has signed a Manufacturer's Representative agreement with We Grow BC Ltd., a Vancouver-based licensed producer of premium cannabis, to become We Grow's exclusive sales representative across Canada. The Agreement adds a second brand of premium B.C.-bud to be sold alongside Aphria's expanding portfolio of adult-use brands, which includes celebrated B.C.-bud from Broken Coast Cannabis, through the Company's coast-to-coast sales distribution network.
"Aphria has an unmatched ability to offer a cross-Canada sales and distribution network for adult-use cannabis," said Jakob Ripshtein, Chief Commercial Officer at Aphria. "We are pleased to complement our existing, and soon-to-be unveiled, in-house adult-use brands with an expanding portfolio of partner brands like We Grow. With our well-established relationships and an extensive network of distribution facilities and resources, we are confident that all our brands, and those of our partners, will be proudly represented in stores and online throughout the country."
Aphria's sales team is supported by Great North Distributors, a subsidiary of Southern Glazer's Wine & Spirits, which was previously announced as Aphria's exclusive cannabis representative in Canada, providing the Company with 100% coverage of all cannabis retailers, whether provincially or privately operated, from the first day of legal adult-use sales.


Aurora Cannabis Inc. and Alcanna Inc. today announced that the companies have reached  a license agreement whereby Alcanna has been given  exclusive rights to open retail cannabis stores under the brand name "Aurora" across Canada. Alcanna's position as the biggest private sector liquor retailer in Canada, aligns with Aurora's position as one of the world's leading cannabis companies.
In February, Aurora announced its strategic investment in Alcanna (formerly Liquor Stores NA), the Edmonton, Alberta-based retailer of alcoholic beverages with 229 retail outlets in Western Canada and Alaska, with a view to establishing a leading brand of cannabis retail outlets. This forward-thinking partnership combines Aurora's brand leadership, high-quality products, customer care and scientific innovations with Alcanna's well-established retailing infrastructure and expertise. Over the last 25 years, Alcanna has established an exemplary track-record of responsibly retailing controlled substances in retail environments that require strict compliance with government regulations.
The stores will operate under the "Aurora" banner, but will represent a house of brands, carrying a carefully curated, but broad selection of products from Licensed Producers across Canada, including Aurora, MedReleaf and CanniMed.

Canopy Growth Corporation and its wholly owned subsidiary, Canopy Health Innovations Inc. announced that approval has been received from the Veterinary Drug Directorate of Health Canada to research the effectiveness of cannabidiol ("CBD") to treat anxiety in certain animals. The research will be conducted by Canopy Animal Health ("CAH"), a division of Canopy Health which focuses on developing cannabis-based healthcare products for companion animals.

The approval comes in the form of a No Objection Letter for the use of a proprietary CBD enriched oil formulation, previously administered in preclinical dosing and safety studies, as a potential therapy for anxiety. The CBD formulation will be produced by Canopy Growth in its GMP-certified production facility in Smiths Falls, Ontario.

Canopy Animal Health, the global leader in cannabinoid science for pets, continues to build a strong portfolio of safety and dosing data for certain animals which it plans to share with the veterinary community and pet owners, through publications and scientific conferences.

CannTrust Holdings Inc., one of Canada's leading licensed producers and most trusted brands of cannabis announced today that the Company is accelerating its exclusive partnership with Apotex Inc., the largest Canadian-owned generic pharmaceutical company and a global leader and innovator in the production and distribution of high-quality, affordable medicines. Ahead of schedule, the partnership is developing alternate dosage formats for medical cannabis products, which will advance CannTrust's leadership in the medical cannabis market in Canada, and on a global basis. The Companies are increasing their focus on extensive research and development. The result will be innovative new products and competitive additions to the CannTrust portfolio, including both quick release and sustained release formats for THC and CBD. This advancement will provide more choice to meet the growing demand from both healthcare practitioners and their patients for standardized cannabis dosages. 

Cannvas MedTech Inc., a leading business technology company in the cannabis space, is pleased to announce the completion of it's Machine Learning integration milestone within the CANNVAS.ME platform, set to launch summer 2018..
"This is a significant achievement for our development team here at Cannvas," said Radu Puscasu, Vice President of Technology, Cannvas MedTech Inc. "Our mission to provide education without outside influences is further enhanced as we implement true user-driven site interaction technologies. We look forward to achieving additional milestones as we continue to push the technology boundaries for the Cannvas.me platform."
As customers engage with the online Cannvas.me platform and interactions continue to increase, our Machine Learning technology is also learning from each interaction. Utilizing this proprietary form of artificial intelligence, the education platform is able to learn from user's interactions and engagement behaviour in a continuous fashion. The intelligent use of this data allows for a highly relevant and immersive user experience that is based on each individual's unique set of behavioural data. This allows Cannvas.me to serve personalized content and educational materials from its Cannvas Academy that are tailored to the individual’s cannabis journey of education.

MYM Nutraceuticals Inc., announced that it has entered into an agreement with Amsterdam-based Dutch Passion Seed Company for the production and distribution of Dutch Passion branded products and seed genetics in Colombia. This follows the August 1 announcement of a similar agreement between Dutch Passion and MYM for production and distribution of branded products and seed genetics in Australia.
Established in 1987, Dutch Passion is the second-oldest European Cannabis seed company and for over 30 years has been a leading innovator of seed genetics. Dutch Passion has developed its own proprietary genetics and owns a seed collection of international cannabis genetics dating back to the 1970s. The company has won more than 50 Cannabis Cups for its high-THC, easy-to-grow varieties. Dutch Passion also invented feminized cannabis seeds in the 1990s and, more recently, helped pioneer the success of high-THC auto-flowering cannabis seeds.


Investor ideas reminds all listeners to read our disclaimers and disclosures on the investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   



Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the Stock Guru daily podcast on Support and Resistance Trading.


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp


Follow us on Social Media





Contact Investorideas.com

800-665-0411




Do you trade or invest in Marijuana / Hemp Stocks?  Check out our stock directory of publicly traded  CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks
Join our Group on Linkedin  and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing


No comments:

Post a Comment